A Local Non Interventional Retrospective Register Study of the Current Clinical Treatment Practices and the Number of Hospitalization Days With Seroquel or Seroquel Prolong.
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2011
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders; Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 15 Feb 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 15 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2010 Planned end date changed from 1 Nov 2009 to 1 Oct 2010 as reported by ClinicalTrials.gov.